ºÝºÝߣ

ºÝºÝߣShare a Scribd company logo
OnQHealth

Carevive

14 ºÝºÝߣShares6 Followers1 Following
14 ºÝºÝߣShares6 Followers1 Following
Personal Information
Organization / Workplace
Miami/Fort Lauderdale Area United States
Occupation
Chief Marketing Officer at Carevive Systems
Industry
Medical / Health Care / Pharmaceuticals
Website
https://www.carevive.com
About
We can transform cancer care by helping providers, researchers and patients work together to fight cancer.
Contact Details

Presentations(11)Ìý

See all
Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology
Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology
Predictors of Symptom Worsening or Improvement using Remote Patient Reported Outcomes (PRO) Technology
Ìý
AMCCBS Virtual 2021 Conference Takeaways Part 2
AMCCBS Virtual 2021 Conference Takeaways Part 2AMCCBS Virtual 2021 Conference Takeaways Part 2
AMCCBS Virtual 2021 Conference Takeaways Part 2
Ìý
AMCCBS Virtual 2021 Conference Takeaways Part 1
AMCCBS Virtual 2021 Conference Takeaways Part 1AMCCBS Virtual 2021 Conference Takeaways Part 1
AMCCBS Virtual 2021 Conference Takeaways Part 1
Ìý

Documents(3)Ìý

Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treatment Updates and Implications
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treatment Updates and ImplicationsGeriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treatment Updates and Implications
Geriatric Assessment in Older Patients with Acute Myelogenous Leukemia: Treatment Updates and Implications
Ìý
What’s New in Acute Myelogenous Leukemia?
What’s New in Acute Myelogenous Leukemia?What’s New in Acute Myelogenous Leukemia?
What’s New in Acute Myelogenous Leukemia?
Ìý
Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic LeukemiaEvidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Evidence-Based Clinical Updates in the Treatment of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia
Ìý